Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multiple-dose up-titration PK, safety and tolerability study of sulthiame (SASS-002) in healthy Japanese and White adults
jRCT2071250138Phase 1Recruiting
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial in obstructive sleep apnea hypopnea syndrome (OSAHS) comparing SASS-002 (sulthiame) with Placebo (2 arms). Primary endpoint: Pharmacokinetic parameters of SASS-002. Started Mar 2026; status: recruiting.
02
Drugs
sultiame
03
Conditions
obstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on jRCT2071250138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071250138.